KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Cash (2017 - 2025)

Guardant Health's Change in Cash history spans 9 years, with the latest figure at -$200.1 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 241.39% year-over-year to -$200.1 million; the TTM value through Dec 2025 reached -$140.3 million, up 72.15%, while the annual FY2025 figure was -$140.3 million, 72.15% up from the prior year.
  • Change in Cash for Q4 2025 was -$200.1 million at Guardant Health, down from -$46.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $676.3 million in Q4 2023 and bottomed at -$358.3 million in Q2 2022.
  • The 5-year median for Change in Cash is -$31.3 million (2022), against an average of -$17.2 million.
  • The largest annual shift saw Change in Cash tumbled 616.41% in 2022 before it surged 4158.59% in 2023.
  • A 5-year view of Change in Cash shows it stood at -$340.4 million in 2021, then soared by 95.1% to -$16.7 million in 2022, then soared by 4158.59% to $676.3 million in 2023, then plummeted by 108.67% to -$58.6 million in 2024, then crashed by 241.39% to -$200.1 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Change in Cash are -$200.1 million (Q4 2025), -$46.0 million (Q3 2025), and -$68.4 million (Q2 2025).